FDA moves toward easing restrictions on certain peptides BioPharma Dive Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to GHK Cu + TB 500 + BPC 157 (BLEND) 70MG Oneday Compounds FDA takes first step in possible reversal of ban on some peptides The Washington Post When will the FDA reclassify BPC 157 to Category 1 Octagon AI The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York